Resources
Gender-Transformative Accelerator - Ethiopia Country Report
Resource date: Dec 2021
Publisher: United Nations Population Fund (UNFPA) and United Nations Children’s Fund (UNICEF)
1
Resources
Gender-Transformative Accelerator Tool - Workshop Facilitation Guide
Resource date: Oct 2021
Publisher: United Nations Population Fund (UNFPA) and United Nations Children’s Fund (UNICEF)
1
Back to page
Resources
Gender-Transformative Accelerator Tool - Brief
Resource date: Oct 2021
Publisher: United Nations Population Fund (UNFPA) and United Nations Children’s Fund (UNICEF)
1
Back to page
Publication
Gender-Transformative Accelerator
Number of pages: 23
Publication date: 01 Oct 2021
Publisher: United Nations Population Fund (UNFPA) and United Nations Children’s Fund (UNICEF)
1
Back to page
Updates
Announcing the Winners of the Joint Innovation Challenge 2022
01 Aug 2022
1
Back to page
Statement
Statement of the Generation Equality Forum (GEF) Action Coalition on Bodily Autonomy and SRHR on the Overturn of Roe v. Wade
03 August 2022
1
Back to page
Joint Independent Common Country Programme Evaluation: Republic of Cabo Verde
The Republic of Cabo Verde is a lower middle-income country with a stable democracy. It faces some structural economic challenges, mostly due to its location and topography, which were exacerbated by the devastating impact of the COVID-19 pandemic on tourism, the sector the country depends on for income and jobs.
In Cabo Verde, UNDP, UNFPA and UNICEF work together as a Joint Office, with the aim of presenting a unified presence and integrated programme delivery. The implementation of this model still faces challenges due to the lack of integrated financial and accountability instruments.
The Common Country Programme rolled out by the Joint Office made some important contributions to the country’s development results. Notable successes are in its support for new education, health and energy policies, provision of cash assistance and COVID-19 vaccines, and the promotion of gender equality.
Moving forward, as the three agencies continue their support to Cabo Verde, the next Common Country Programme should fully establish the Joint Office governance model, with all of its checks and balances. In addition, the Joint Office should step up its efforts to assist the Government to identify new sources of financing to support sustainable and equitable recovery post-pandemic.
This Joint Independent Common Country Programme Evaluation was jointly commissioned by the Independent Evaluation Office of UNDP, UNFPA Evaluation Office and the Evaluation Office of UNICEF. The evaluation covers the United Nations Common Country Programme interventions implemented between 2018 to 2022.
Evaluation Documents:
Additional Resources:
News
Speaking out for sexual and reproductive health and rights in Egypt
- 28 July 2022
1
Back to page
Mid-term evaluation of the Maternal and Newborn Health Thematic Fund Phase III 2018-2022
The Maternal and Newborn Health Thematic Fund (MHTF) is a key contributor to the UNFPA presence and leadership of maternal health at the global level. The MHTF was established in 2008, and this evaluation covers its third phase from 2018 to 2022.
The evaluation assesses the extent to which the MHTF has contributed to strengthening health systems, improving quality of care, and advancing equity, human rights and accountability to stakeholders in 32 high-burden countries. It determines MHTF’s ability to scale up integration of sexual and reproductive health and rights (SRHR) with maternal and newborn health (MNH) services. The evaluation also identifies key lessons and challenges of the MHTF that will inform its next phase.
The evaluation finds that, with the MHTF, UNFPA is a partner of choice providing visible and valued support to critical MNH priorities. The MHTF is a technically sophisticated tool for supporting MNH in programme countries, especially in its four priority areas of midwifery, emergency obstetric and newborn care (EmONC), Maternal and Perinatal Death Surveillance and Response (MPDSR) and fistula. Midwifery is the anchor of the MHTF and the cornerstone of the UNFPA MNH response. The MHTF delivers value for money, both globally and for individual countries. However, the MHTF is not clearly positioned within a holistic UNFPA MNH strategic framework. If not addressed, critical gaps highlighted by the evaluation will limit the relevance and the sustainability of the MHTF investments.
The evaluation recommends the MHTF to expand into a new phase focusing on SRHR-MNH integration and support. The MHTF should also be positioned within a comprehensive UNFPA maternal health strategy and action plan.
Evaluation Documents:
Every year, 70,000 women die from excessive bleeding after childbirth (post-partum haemorrhage or PPH), with the majority of deaths occurring in low- and lower-middle income countries. The majority of PPH deaths could be avoided through preventative approaches, however, this is not always the reality for those living in humanitarian crisis settings, for example conflict regions, natural disasters, public health emergencies.
The United Nations Population Fund (UNFPA) and Ferring Pharmaceuticals share a collective goal in working towards achieving zero preventable maternal deaths. Making motherhood safer is a human rights imperative. This is only possible by ensuring that every woman has access to quality care and treatment during pregnancy and childbirth, no matter where she lives. It is in this context that UNFPA is collaborating with Ferring Pharmaceuticals to contribute to the body of evidence regarding the safe introduction of additional resources such as heat stable carbetocin for the prevention of excessive bleeding after birth (post-partum hemorrhage)in low resource humanitarian contexts such as Uganda and South Sudan. Through this, both organisations aim to contribute to providing access to safe birth in the most vulnerable settings. This collaboration is also part of Ferring’s commitment at the 25th anniversary of the International Conference on Population and Development (ICPD25) held in November 2019.
World Health Organization has found the use of good quality prophylactic uterotonics can prevent the majority of PPH associated complications during the third stage of labour. Heat-stable carbetocin does not require refrigeration to be stored or transported, which can be life-saving in regions with high temperatures or where there may be unpredictable power sources.
In addition to the drugs oxytocin and misoprostol, heat-stable carbetocin is recommended for the prevention of PPH for all births in contexts where its cost is comparable to other effective uterotonics. The World Health Organization (WHO) updated the PPH prevention recommendations to include carbetocin in 2018 and added the heat-stable formulation of carbetocin to the Essential Medicines List of uterotonics in 2019.
South Sudan
Ten years after independence, South Sudan still endures staggering levels of violence across several regions of the country. According to a UNHCR, nearly 1.6 million persons are internally displaced and some 345,000 returnees, who have spontaneously returned to South Sudan, are affected by the violence and search for safe harbors. The maternal mortality ratio for South Sudan in 2017 was 1,150 deaths out of every 100,000 live births. The project areas include six health facilities that cater for the most part to the internally displaced population. Together these facilities report close to 600 births per month.
Uganda
Regional conflicts have driven people from more than eight countries to seek refuge and asylum in Uganda’s North and Northwest Regions. A UNHCR report documented that Uganda was host to over 1.4 million refugees and asylum seekers in January 2021. According to a Knoema statistic, the maternal mortality ratio in Uganda in 2017 was 375 deaths out of every 100,000 live births. For Uganda, six locations are proposed in and around the main refugee camps in the areas of Bidibidi and Mvepi, covering both the refugee and national population. Together, these health facilities report 235 births per month.